| [1] |
Guo Y, Wang J, Wu W, et al. Incidence of ischemia reperfusion injury related biliary complications in livertransplantation: effect of different types of donors[J].Transplant Proc, 2022, 54(7):1865-1873.
|
| [2] |
Rossi AF, Grosso C, Zanasi G, et al. Endoscopicmanagement of biliary complications after orthotopicliver transplantation[J]. Gastroenterology, 1998, 114:A538.
|
| [3] |
Michael FA, Friedrich-rust M, Erasmus HP, et al. Treatment of non-anastomotic biliary stricturesafter liver transplantation: how effective is our currenttreatment strategy?[J]. J Clin Med, 2023, 12(10):3491.
|
| [4] |
Liao M, Guo H, Tong G, et al. Can ultrasonographydifferentiate anastomotic and non-anastomotic biliarystrictures after orthotopic liver transplantation- a single-center experience[J]. Eur J Radiol, 2021, 134:109416.
|
| [5] |
杨扬, 王金锐, 郑荣琴, 等. 中国大陆地区肝移植后缺血性胆道病变诊断及治疗专家共识[J]. 器官移植, 2015, 1(1):1-5.
|
| [6] |
Ren J, Lu MD, Zheng RQ, et al. Evaluation of themicrocirculatory disturbance of biliary ischemia afterliver transplantation with contrast-enhanced ultrasound:preliminary experience[J]. Liver Transpl, 2009, 15(12):1703-1708.
|
| [7] |
Ren J, Zheng BW, Wang P, et al. Revealingimpaired blood supply to the bile ducts on contrast-enhanced ultrasound: a novel diagnosis method toischemic-type biliary lesions after orthotropic livertransplantation[J]. Ultrasound Med Biol, 2013, 39(5):753-760.
|
| [8] |
Xu YB, Min ZG, Jiang HX, et al. Diagnostic value ofmagnetic resonance cholangiopancreatography for biliarycomplications in orthotopic liver transplantation: a meta-analysis[J]. Transplant Proc, 2013, 45(6):2341-2346.
|
| [9] |
Kinner S, Schubert TB, Said A, et al. Addedvalue of gadoxetic acid-enhanced T1-weighted magneticresonance cholangiography for the diagnosis of post-transplant biliary complications[J]. Eur Radiol, 2017, 27(10):4415-4425.
|
| [10] |
Wang J, Liu JJ, Liang YY, et al. Could diffusion-weighted imaging detect injured bile ducts of ischemic-type biliary lesions after orthotopic livertransplantation?[J]. Am J Roentgenol, 2012, 199(4):901-906.
|
| [11] |
Boraschi P, Donati F, Pacciardi F, et al. Biliary complications after liver transplantation:assessment with MR cholangiopancreatography and MRimaging at 3T device[J]. Eur J Radiol, 2018, 106: 46-55.
|
| [12] |
Urbani l, Mazzoni A, Bianco I, et al. The role ofimmunomodulation in ABO-incompatible adult livertransplant recipients[J]. J Clin Apher, 2008, 23(2):55-62.
|
| [13] |
Farid WR, De Jonge J, Zondervan PE, et al. Relationship between the histological appearance of theportal vein and development of ischemic-type biliarylesions after liver transplantation[J]. Liver Transpl, 2013, 19(10):1088-1098.
|
| [14] |
Seehofer D, Rayes N, Tullius SG, et al. CMVhepatitis after liver transplantation: incidence, clinicalcourse, and long-term follow-up[J]. Liver Transpl, 2002, 8(12):1138-1146.
|
| [15] |
Dubbeld J, Hoekstra H, Farid W, et al. Similarliver transplantation survival with selected cardiac deathdonors and brain death donors[J]. Br J Surg, 2010, 97(5):744-753.
|
| [16] |
Suárez F, Otero A, Solla M, et al. Biliarycomplications after liver transplantation from maastrichtcategory-2 non-heart-beating donors[J]. Transplantation, 2008, 85(1):9-14.
|
| [17] |
Hessheimer AJ, Cárdenas A, García-valdecasas JC, et al. Can we prevent ischemic-typebiliary lesions in donation after circulatory determinationof death liver transplantation?[J]. Liver Transpl, 2016, 22(7):1025-1033.
|
| [18] |
Durán M, Calleja R, Hann A, et al. Machineperfusion and the prevention of ischemic type biliarylesions following liver transplant: what is theevidence?[J]. World J Gastroenterol, 2023, 29(20):3066-3083.
|
| [19] |
Gastaca M, Guerra M, Alvarez martinez L, et al. Octogenarian donors in liver transplantation[J]. Transplant Proc, 2016, 48(9):2856-2858.
|
| [20] |
Firl DJ, Hashimoto K, O'rourke C, et al. Impactof donor age in liver transplantation from donation aftercirculatory death donors: a decade of experience atCleveland Clinic[J]. Liver Transpl, 2015, 21(12):1494-1503.
|
| [21] |
Giannella M, Freire M, Rinaldi M, et al. Development of a risk prediction model for carbapenem-resistant Enterobacteriaceae infection after livertransplantation: a multinational cohort study[J]. ClinInfect Dis, 2021, 73(4):e955-e966.
|
| [22] |
Heidenhain C, Pratschke J, Puhl G, et al. Incidence of and risk factors for ischemic-type biliarylesions following orthotopic liver transplantation[J]. Transpl Int, 2010, 23(1):14-22.
|
| [23] |
Sanchez-urdazpal L, Gores GJ, Ward EM, et al. Clinical outcome of ischemic-type biliarycomplications after liver transplantation[J]. TransplantProc, 1993, 25(1 pt 2):1107-1109.
|
| [24] |
Guichelaar MM, Benson JT, Malinchoc M, et al. Risk factors for and clinical course of non-anastomotic biliary strictures after livertransplantation[J]. Am J Transplant, 2003, 3(7):885-890.
|
| [25] |
Chan EY, Olson LC, Kisthard JA, et al. Ischemiccholangiopathy following liver transplantation fromdonation after cardiac death donors[J]. Liver Transpl, 2008, 14(5):604-610.
|
| [26] |
Abt PL, Desai NM, Crawford MD, et al. Survivalfollowing liver transplantation from non-heart-beatingdonors[J]. Ann Surg, 2004, 239(1):87-92.
|
| [27] |
Lee KW, Simpkins CE, Montgomery RA, et al. Factors affecting graft survival after liver transplantationfrom donation after cardiac death donors[J]. Transplantation, 2006, 82(12):1683-1688.
|
| [28] |
de vera ME, Lopez-solis R, Dvorchik I, et al. Liver transplantation using donation after cardiac deathdonors: long-term follow-up from a single center[J]. AmJ Transplant, 2009, 9(4):773-781.
|
| [29] |
Shcherba A, Kuzmenkova LL, Efimov DJ, et, al. Risk factors and prediction of bacterial complicationsin liver transplantation[J]. HPB Surg, 2023, 28(3):10-20.
|
| [30] |
Cherchi V, Vetrugno L, Zanini V, et al. Association between indocyanine green clearance testand ischemic type biliary lesions within one year afterorthotopic liver transplantation[J]. GastroenterolHepatol, 2021, 44(10):687-695.
|
| [31] |
Stewart ZA, Cameron AM, Singer AL, et al. Histidine-tryptophan-ketoglutarate (HTK) is associatedwith reduced graft survival in deceased donor livers,especially those donated after cardiac death[J]. Am JTransplant, 2009, 9(2):286-293.
|
| [32] |
Adam R, Delvart V, Karam V, et al. Comparedefficacy of preservation solutions in liver transplantation:a long-term graft outcome study from the European LiverTransplant Registry[J]. Am J Transplant, 2015, 15(2):395-406.
|
| [33] |
Lembach jahnsen H, Mergental H, Pereramtpr, et al. Ex-situ liver preservation with machinepreservation[J]. Curr Opin Organ Transplant, 2021, 26(2):121-132.
|
| [34] |
Dries SOD, Sutton ME, Karimian N, et al. Hypothermic oxygenated machine perfusion preventsarteriolonecrosis of the peribiliary plexus in pig liversdonated after circulatory death[J]. PLoS One, 2014, 9(2):e88521.
|
| [35] |
Panayotova G, Lunsford K, Quillin R, et al. Portable hypothermic oxygenated machine perfusion fororgan preservation in liver transplantation: a randomized,open-label, clinical trial[J]. Hepatology, 2024, 79(5):1033-1047.
|
| [36] |
Chen WJ, Ying DJ, Liu ZJ, et al. Analysis of thearterial supply of the extrahepatic bile ducts and itsclinical significance[J]. Clin Anat, 1999, 12(4):245-249.
|
| [37] |
Ramos P, Williams P, Salinas J, et al. Abdominal organ preservation solutions in the age ofmachine perfusion[J]. Transplantation, 2023, 107(2):326-340.
|
| [38] |
Saitta B, Edgington J, Hart T, et al. Applicationof an external fixator vascular compressor (EFVC) in thecritically injured trauma patient: a novel damage controltechnique[J]. Eur J Orthop Surg Traumatol, 2019, 29(6):1337-1345.
|
| [39] |
Abbenante D, Raone B, Baraldi C, et al. Angiokeratoma circumscriptum naeviforme presenting asa dark warty plaque on the leg[J]. Acta DermatovenerolCroat, 2021, 29(3):169-170.
|
| [40] |
Lou Z. Massive presacral bleeding during rectalsurgery: from anatomy to clinical practice[J]. World JGastroenterol, 2013, 19(25):4039.
|
| [41] |
Hashimoto K, Eghtesad B, Gunasekaran G, et al. Use of tissue plasminogen activator in livertransplantation from donation after cardiac deathdonors[J]. Am J Transplant, 2010, 10(12):2665-2672.
|
| [42] |
Burlage LC, Karangwa SA, Lisman T, et al. Thrombolytic protocol minimizes ischemic-type biliarycomplications in liver transplantation from donation aftercirculatory death donors[J]. Liver Transpl, 2015, 21(9):1231-1232.
|
| [43] |
Bang JB, Kim BW, Kim YB, et al. Risk factor forischemic-type biliary lesion after ABO-incompatibleliving donor liver transplantation[J]. World JGastroenterol, 2016, 22(30):6925-6935.
|
| [44] |
Zhang YC, Liu W, Fu BS, et al. Therapeuticpotentials of umbilical cord-derived mesenchymalstromal cells for ischemic-type biliary lesions followingliver transplantation[J]. Cytotherapy, 2017, 19(2):194-199.
|
| [45] |
Egawa H, Teramukai S, Haga H, et al. Presentstatus of ABO-incompatible living donor livertransplantation in Japan[J]. Hepatology, 2008, 47(1):143-152.
|
| [46] |
Zhang Y, Zhang J, Yi H, et al. A novel MSC-basedimmune induction strategy for ABO-incompatible livertransplantation: a phase I/II randomized, open-label,controlled trial[J]. Stem Cell Res Ther, 2021, 12(1):244.
|
| [47] |
Lee TB, Ko HJ, Shim JR, et al. ABO-incompatibleliving donor liver transplantation with a simplifieddesensitization and immunosuppression protocol: asingle-center retrospective study[J]. Exp ClinTransplant, 2021, 19(7):676-685.
|
| [48] |
Nemes B, Gámán G, Doros A. Biliarycomplications after liver transplantation[J]. Expert RevGastroenterol Hepatol, 2015, 9(4):447-466.
|
| [49] |
Shagrani M, Kumar K, Baker A, et al. ABO-incompatible pediatric liver transplantation with antibodyand B-cell depletion-free immunosuppressive protocol inhigh consanguinity communities[J]. Transplant Direct, 2022, 8(12):e1353.
|
| [50] |
Zorzetti N, Lauro A, Khouzam S, et al. Immunosuppression, compliance, and tolerance afterorthotopic liver transplantation: state of the art[J]. ExpClin Transplant, 2022, 20(suppl 1):3-9.
|
| [51] |
Wang W, Zheng S, Shong Z, et al. Development ofa guinea pig model of perinatal cytomegalovirus-induced hepatobiliary injury[J]. Fetal Pediatr Pathol, 2011, 30(5):301-311.
|
| [52] |
Engelmann C, Sterneck M, Weiss KH, et al. Prevention and management of CMV infections afterliver transplantation: current practice in Germantransplant centers[J]. J Clin Med, 2020, 9(8):2352.
|
| [53] |
Razonable RR. Cytomegalovirus infection after livertransplantation: current concepts and challenges[J]. World J Gastroenterol, 2008, 14(31):4849-4860.
|
| [54] |
Lautenschlager I. CMV infection, diagnosis andantiviral strategies after liver transplantation[J]. TransplInt, 2009, 22(11):1031-1040.
|
| [55] |
Razonable RR, Humar A. Cytomegalovirus insolid organ transplant recipients-Guidelines of theAmerican Society of Transplantation Infectious DiseasesCommunity of Practice[J]. Clin Transplant, 2019, 33(9):e13512.
|
| [56] |
Tang JX, Zhang K, Fang TS, et al. Outcomes of ABO-incompatible liver transplantation in end-stageliver disease patients co-infected with hepatitis B andhuman immunodeficiency virus[J]. World JGastroenterol, 2023, 29(11):1745-1756.
|
| [57] |
Kienlein S, Schoening W, Andert A, et al. Biliary complications in liver transplantation: impact ofanastomotic technique and ischemic time on short-andlong-term outcome[J]. World J Transplant, 2015, 5(4):300-309.
|
| [58] |
He L, Fu Z, Wang M, et al. Prevention and treatmentof carbapenem-resistant organism bacilli from livertransplantation donors - single center experience[J]. Infect Drug Resist, 2022, 15: 47-52.
|
| [59] |
Kamal SM, Wahed A, Abdelhakam S. Role ofERCP in management of bacterial cholangitis in living-donor liver transplant recipients with biliarycomplications: a single center study[J]. J Egyptian SocParasitol, 2023, 53:219-225.
|
| [60] |
Magro B, Tacelli M, Mazzola A, et al. Biliarycomplications after liver transplantation: currentperspectives and future strategies[J]. Hepatobiliary SurgNutr, 2021, 10(1):76-92.
|
| [61] |
Sharma S, Gurakar A, Jabbour N. Biliarystrictures following liver transplantation: past, presentand preventive strategies[J]. Liver Transpl, 2008, 14(6):759-769.
|
| [62] |
Park H, Han ES, Park SJ, et al. Anatomicalclassification and clinical outcomes of biliary stricturesin living donor liver transplantation using right livergrafts[J]. Liver Transplant, 2022, 29(3):307-317.
|
| [63] |
Sheng R, Ramirez CB, Zajko AB, et al. Biliarystones and sludge in liver transplant patients: a 13-yearexperience[J]. Radiology, 1996, 198(1):243-247.
|
| [64] |
Katariya N, Mathur AK. Biliary strictures: a surgeon's perspective for interventional radiologists[J]. Semin Intervent Radiol, 2021, 38(3):273-279.
|
| [65] |
Seehofer D, Eurich D, Veltzke-schliekerw, et al. Biliary complications after liver transplantation:old problems and new challenges[J]. Am J Transplant, 2013, 13(2):253-265.
|
| [66] |
Saleem A, Baron TH, Gostout CJ, et al. Endoscopic retrograde cholangiopancreatography using asingle-balloon enteroscope in patients with altered Roux-en-Y anatomy[J]. Endoscopy, 2010, 42(8):656-660.
|
| [67] |
Zoepf T, Maldonado de dechêne ej, Dechêne A, et al. Optimized endoscopic treatment ofischemic-type biliary lesions after livertransplantation[J]. Gastrointest Endosc, 2012, 76(3):556-563.
|
| [68] |
Ferreira MTGB, Ribeiro IB, De moura dth, et al. Stent versus balloon dilation for the treatment ofdominant strictures in primary sclerosing cholangitis: asystematic review and meta-analysis[J]. Clin Endosc, 2021, 54(6):833-842.
|
| [69] |
Yan KL, Gomes AS, Monteleone PA, et al. Management of biliary stricture in pediatric livertransplantation patients: long-term outcomes[J]. LiverTranspl, 2021, 27(12):1788-1798.
|
| [70] |
Valentino PL, Wang T, Shabanova V, et al. North American biliary stricture management strategiesin children after liver transplantation: a multicenteranalysis from the society of pediatric livertransplantation (SPLIT) registry[J]. Liver Transpl, 2022, 28(5):819-833.
|
| [71] |
Buis CI, Hoekstra H, Verdonk RC, et al. Causesand consequences of ischemic-type biliary lesions afterliver transplantation[J]. J Hepatobiliary Pancreat Surg, 2006, 13(6):517-524.
|
| [72] |
Chen Z, Ju W, Chen C, et al. Application of varioussurgical techniques in liver transplantation: aretrospective study[J]. Ann Transl Med, 2021, 9(17):1367.
|
| [73] |
Schlitt HJ, Meier PN, Nashan B, et al. Reconstructive surgery for ischemic-type lesions at thebile duct bifurcation after liver transplantation[J]. AnnSurg, 1999, 229(1):137-145.
|
| [74] |
Dubbeld J, Van hoek B, Ringers J, et al. Biliarycomplications after liver transplantation from donationafter cardiac death donors: an analysis of risk factors andlong-term outcome from a single center[J]. Ann Surg, 2015, 261(3):e64.
|
| [75] |
Belli LS, Duvoux C, Artzner T, et al. Livertransplantation for patients with acute-on-chronic liverfailure (ACLF) in Europe: results of the ELITA/EF-CLIFcollaborative study (ECLIS)[J]. J Hepatol, 2021, 75(3):610-622.
|